(Q53475443)

14 May 2018

title

P53 accumulation in precursor lesions and early stages of bladder cancer. (English)

1 reference

14 May 2018

author

Wolfgang A. Schulz

6

1 reference

14 May 2018

author name string

B J Schmitz-Dräger

1

1 reference

14 May 2018

C R van Roeyen

2

1 reference

14 May 2018

M O Grimm

3

1 reference

14 May 2018

C D Gerharz

4

1 reference

14 May 2018

K Decken

5

1 reference

14 May 2018

H Bültel

7

1 reference

14 May 2018

D Makri

8

1 reference

14 May 2018

T Ebert

9

1 reference

14 May 2018

R Ackermann

10

1 reference

14 May 2018

publication date

1 January 1994

1 reference

14 May 2018

published in

World Journal of Urology

1 reference

14 May 2018

volume

12

1 reference

14 May 2018

page(s)

79-83

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00184241

exact match

0 references

cites work

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

12 December 2020

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

12 December 2020

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

1 reference

12 December 2020

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

12 December 2020

Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

1 reference

12 December 2020

The p53 tumour suppressor gene

1 reference

12 December 2020

Cancer. p53, guardian of the genome

1 reference

12 December 2020

Urothelial dysplasia.

1 reference

12 December 2020

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication

1 reference

12 December 2020

Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder

1 reference

12 December 2020

Presence of a potent transcription activating sequence in the p53 protein

1 reference

12 December 2020

Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53

1 reference

12 December 2020

Biological markers in transurethral biopsies from bladder-cancer - preliminary-results.

1 reference

12 December 2020

Definition of a consensus binding site for p53

1 reference

12 December 2020

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

12 December 2020

Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells

1 reference

12 December 2020

Participation of p53 protein in the cellular response to DNA damage

1 reference

12 December 2020

Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype

1 reference

12 December 2020

Molecular genetic alterations in superficial and locally advanced human bladder cancer

1 reference

12 December 2020

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

12 December 2020

Genetic alterations during colorectal-tumor development

1 reference

12 December 2020

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder

1 reference

12 December 2020

Frequent association of p53 gene mutation in invasive bladder cancer

1 reference

12 December 2020

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

12 December 2020

p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00184241

1 reference

14 May 2018

PubMed ID

8087143

1 reference

14 May 2018